EFSCE
ACHN

Enterprise Financial Services Corp (EFSC)’s Achillion Pharmaceuticals ACHN Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-388
Closed -$3K – 1111
2016
Q3 		$3K Hold
388
– – ﹤0.01% 839
2016
Q2 		$3K Sell
388
-103
-21% -$884 ﹤0.01% 812
2016
Q1 		$4K Buy
+491
New +$3.6K ﹤0.01% 768
2015
Q2 		– Sell
-209
Closed -$2K – 1260
2015
Q1 		$2K Hold
209
– – ﹤0.01% 1060
2014
Q4 		$3K Buy
+209
New +$2.55K ﹤0.01% 962

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s ACHN Position: Q4 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 388 shares — an estimated $3K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ACHN in Q4 2014 and held it in 5 quarters. The position peaked at $4K in Q1 2016. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 388 Achillion Pharmaceuticals shares in Q4 2016, an estimated $3K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Achillion Pharmaceuticals position peaked at $4K in Q1 2016.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2016, filed 26 Jan 2017.